The first ovarian cancer trial in three years over Johnson & Johnson’s talcum powder wrapped up on Friday before jurors in Miami.

The trial, which began on Feb. 13, is the first against Johnson & Johnson since a bankruptcy judge tossed subsidiary LTL Management’s second Chapter 11 cases last year.